A carregar...
Riociguat: Something new in pulmonary hypertension therapeutics?
Pulmonary hypertension (PH) continues to be a disease that is associated with woeful outcomes. The search for an ideal drug molecule for PH led to the discovery of riociguat, which is a first-in-class drug molecule that activates soluble guanylate cyclase. We conducted a systematic literature search...
Na minha lista:
| Publicado no: | J Pharmacol Pharmacother |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319244/ https://ncbi.nlm.nih.gov/pubmed/25709345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.149132 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|